206
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy

, , , , &
Pages 349-354 | Published online: 29 Jul 2019

References

  • Tikmani SS, Warraich HJ, Abbasi F, Rizv A, Darmstadt GL, Zaidi AKM. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan. Trop Med Int Health. 2010;15:502–507. doi:10.1111/j.1365-3156.2010.02584.x20412075
  • Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 2005;25:54–59. doi:10.1038/sj.jp.721115715578034
  • Bratlid D, Nakstad B, Hansen TWR. National guidelines for treatment of jaundice in the newborn. Acta Paediatr. 2011;100:499. doi:10.1111/j.1651-2227.2010.02104.x21114525
  • Rennie JM, Sehgal A, De A, Kendall GS, Cole TJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed. 2009;94:F323–7. doi:10.1136/adc.2008.14768619000996
  • Snook J. Is home phototherapy in the term neonate with physiological jaundice a feasible practice? A systematic literature review. J Neonatal Nurs. 2016; Accessed December 2nd 2016. doi:10.1016/j.jnn.2016.08.001
  • Eggert LD, Pollary RA, Folland DS, Jung AL. Home phototherapy treatment of neonatal jaundice. Pediatrics. 1985;76:579–584.4047802
  • Murki S, Dutta S, Narang A, Sarkar U, Garewal G. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol. 2005;25:325–330. doi:10.1038/sj.jp.721125815716985
  • Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics. 2001;108:25–30. doi:10.1542/peds.108.6.136711433050
  • Bhatia V, Bavdekar A, Matthal J, Waikar Y, Sibal A. Management of neonatal cholestasis: consensus statement of the pediatric gastroenterology chapter of Indian Academy of Pediatrics. Indian Pediatr. 2014;15:203–210. doi:10.1007/s13312-014-0375-2
  • Best C, Gourley GR. Management of neonatal cholestasis. Therapy. 2009;6:75–81. doi:10.2217/14750708.6.1.75
  • Lirussi F, Okolicsanyi L. Cytoprotective with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease. Ital J Gastroenterol. 1992;24:31–35.1571577
  • Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hepatology. 1995;22:82–87. doi:10.1002/hep.18402201137601437
  • Cuperus FJC, Iemhoff AA, Verkade HJ. Combined treatment strategies for unconjugated hyperbilirubinemia in gunn rats. Pediatr Res. 2011;70:560–565. doi:10.1203/PDR.0b013e31822e63b321857383
  • Palmela I, Correla L, Silva R, et al. Hydrohilic bile acids protect human blood brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study. Front Neurosci. 2015;9:80. doi:10.3389/fnins.2015.0008025821432
  • Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. J. Pediatr Gastroenterol Nutr. 2016;62:97–100. doi:10.1097/MPG.000000000000087426020375
  • Hassan A, Babadoko AA, Ahmed AJ, Suleiman AM. The pattern of distribution of ABO blood groups in North Western Nigeria. Ann Niger Med. 2005;1:17–18.
  • Jafari S, Khan KA, Bhatnagar S, Srivastava G, Nanda C, Chandra A. Role of ursodeoxycholic acid in neonates with indirect hyperbilirubinemia-an open labelled randomized control trial. Int J of Contemp Pediatr. 2018;5(2):432–435. doi:10.18203/2349-3291.ijcp20180530
  • Yurdakok M. Phototherapy in the newborn: what’s new? J Pediatr Neonatal Individualized Med. 2015;4(2):e040255. doi:10.7363/040255
  • Maisels MJ, McDonagh A. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920–928. doi:10.1056/NEJMct070837618305267
  • Zonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Derm. 2001;117(6):1452–1457. doi:10.1046/j.1523-1747.2001.01378.x11886508
  • British Pharmacopoeia. Available from: https://www.pharmacopoeia.com. Accessed March 9, 2018.
  • American Academy of Pediatrics. Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi:10.1542/peds.114.1.29715231951
  • Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193–1198. doi:10.1542/peds.2009-032919786452
  • Brown AK, Kim BM, Paul Y, Wu K, Dolores AB. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75:393–400.3881731
  • Oyedeji GA. Socioeconomic and cultural background of hospitalized children in Ilesa. Nig J Paediatr. 1995;12:111–117.
  • Montquin JM. Classification and heterogeneity of preterm births. BJOG. 2003;110(20):30–33. doi:10.1046/j.1471-0528.2003.00021.x12763108
  • Chlesa C, Panero A, Osborn JF, Simoneti AF, Pacifico SL. Diagnosis of neonatal sepsis: a clinical and laboratory challenges. Clin Chem. 2004;50(2). doi:10.1373/clinchem2003.025171
  • Maldonado SR, Tellez NCG, Yescas-Buendia G, Rios ERR. Effectiveness of ursodeoxycholic acid vs phenobarbital for the treatment of neonatal cholestasis: a cross-randomized clinical trial. Bol Med Hosp Infant Mex. 2010;67:418–424.